Use of blinatumomab as bridge therapy before allogeneic bone marrow transplantation in patients with acute b-lymphoblastic leukemia (b-all)
| dc.contributor.author | Dubina, M. | |
| dc.contributor.author | Iskrou, I. | |
| dc.contributor.author | Lendzina, I. | |
| dc.contributor.author | Kabayeva, K. | |
| dc.date.accessioned | 2025-06-16T13:46:47Z | |
| dc.date.available | 2025-06-16T13:46:47Z | |
| dc.date.issued | 2024 | |
| dc.identifier.uri | https://rep.bsmu.by/handle/BSMU/49411 | |
| dc.description | Use of blinatumomab as bridge therapy before allogeneic bone marrow transplantation in patients with acute b-lymphoblastic leukemia (b-all) / M. Dubina, I. Iskrou, I. Lendzina, K. Kabayeva // HemaSphere. – 2024. – Vol. 8, suppl. 1 [EHA 2024 : 29th Hybrid Congr. of the Europ. Hematology Assoc., Madrid, 13-16 June 2024 : abstr. book]. – P. 4471–4472. – URL: https://onlinelibrary.wiley.com/toc/25729241/2024/8/S1 | ru_RU |
| dc.language.iso | en | ru_RU |
| dc.title | Use of blinatumomab as bridge therapy before allogeneic bone marrow transplantation in patients with acute b-lymphoblastic leukemia (b-all) | ru_RU |
| dc.type | Article | ru_RU |
